Kousaku Ohinata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kousaku Ohinata has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Ryuhei Kanamoto
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Japan
13 shared publicationsKentaro Kaneko
Division of Food Science and Biotechnology, Graduate School of Agriculture Kyoto University Kyoto Japan
12 shared publicationsTakafumi Mizushige
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Gokasho Uji, Kyoto, 611-0011, Japan
12 shared publicationsMasaaki Yoshikawa
Division of Food Science and Biotechnology Graduate School of Agriculture Kyoto University Gokasho Uji Kyoto Japan
9 shared publicationsHideyuki Suzuki
Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa-kamatari, Chiba, Kisarazu 292-0818, Japan
8 shared publicationsJunya Nakato
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan
8 shared publications
Latest Publications
- Open Access
- 17 December 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (24) , e71366
Characterization of a Bovine Serum Albumin‐Derived Pro‐Cognitive Peptide ( bSAPP ): An Orally Active Peptide Alleviates Cognitive Decline in HFD ‐Fed Mice via CCK Signaling Through the Gut‐Brain Axis
The global prevalence and burden of dementia continue to rise, driven not only by an aging population but also by obesity associated with unhealthy dietary habits. From a Quality of Life (QoL) perspective, identifying naturally derived compounds that enhance cognitive function is increasingly encouraged alongside pharmaceutical interventions. In this study, we investigated the anti‐dementia effects of a peptide derived from bovine serum albumin using high‐fat diet (HFD)‐fed mice. We first found that the enzymatic digest of bovine serum albumin could orally alleviate cognitive decline induced by HFD. Then, we confirmed the oral pro‐cognitive effects of the peptide derived from the digest and the underlying mechanisms. The peptide had an EC 50 of 0.01 mg/kg BW/day. Therefore, we designated it bSAPP (bovine serum albumin‐derived pro‐cognitive peptide). The cognition‐enhancing effects of bSAPP were blunted by an α7nAChR antagonist, suggesting that the pro‐cognitive effect of bSAPP was mediated by acetylcholine signaling. Moreover, bSAPP became ineffective in the presence of a CCK1R antagonist as well as in CCK1R −/− mice, highlighting the involvement of CCK1R signaling. Furthermore, bSAPP increased the number of BrdU‐positive cells in the dentate gyrus of the hippocampus and upregulated hippocampal expression of VEGF and NGF in a CCK1R‐dependent manner. Additionally, the cognitive benefits of bSAPP were nullified by a capsaicin pre‐treatment. In summary, we observed that bSAPP could orally enhance cognitive function in HFD‐fed mice through CCK1R signaling via the gut‐brain axis, accompanied by facilitated hippocampal cell proliferation and involvement of acetylcholine signaling.
- 17 December 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (24) , e71366
Open AccessCharacterization of a Bovine Serum Albumin‐Derived Pro‐Cognitive Peptide ( bSAPP ): An Orally Active Peptide Alleviates Cognitive Decline in HFD ‐Fed Mice via CCK Signaling Through the Gut‐Brain Axis
The global prevalence and burden of dementia continue to rise, driven not only by an aging population but also by obesity associated with unhealthy dietary habits. From a Quality of Life (QoL) perspective, identifying naturally derived compounds that enhance cognitive function is increasingly encouraged alongside pharmaceutical interventions. In this study, we investigated the anti‐dementia effects of a peptide derived from bovine serum albumin using high‐fat diet (HFD)‐fed mice. We first found that the enzymatic digest of bovine serum albumin could orally alleviate cognitive decline induced by HFD. Then, we confirmed the oral pro‐cognitive effects of the peptide derived from the digest and the underlying mechanisms. The peptide had an EC 50 of 0.01 mg/kg BW/day. Therefore, we designated it bSAPP (bovine serum albumin‐derived pro‐cognitive peptide). The cognition‐enhancing effects of bSAPP were blunted by an α7nAChR antagonist, suggesting that the pro‐cognitive effect of bSAPP was mediated by acetylcholine signaling. Moreover, bSAPP became ineffective in the presence of a CCK1R antagonist as well as in CCK1R −/− mice, highlighting the involvement of CCK1R signaling. Furthermore, bSAPP increased the number of BrdU‐positive cells in the dentate gyrus of the hippocampus and upregulated hippocampal expression of VEGF and NGF in a CCK1R‐dependent manner. Additionally, the cognitive benefits of bSAPP were nullified by a capsaicin pre‐treatment. In summary, we observed that bSAPP could orally enhance cognitive function in HFD‐fed mice through CCK1R signaling via the gut‐brain axis, accompanied by facilitated hippocampal cell proliferation and involvement of acetylcholine signaling.
- Open Access
- 26 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Medium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1
Population aging is the most important social and medical demographic issue worldwide; therefore, healthy aging is important. The increasing prevalence of dementia and cognitive decline are major health concerns. Medium-chain triglycerides (MCTs) have been shown to improve cognitive decline. The present study investigated the effects and mechanisms of action of orally administered MCTs, including tricaprylin (TC8), tricaprin (TC10), and trilaurin (TC12), on cognitive function in mice fed a high-fat diet (HFD). The administration of TC8 and TC10 attenuated cognitive decline. A relationship has been reported between cognitive dysfunction and impaired glucose metabolism. The administration of TC8 and TC10 also reduced blood glucose levels in the glucose tolerance test. Cognitive improvements by MCTs are widely attributed to the ketogenic effect. In the present study, TC8 significantly increased blood ketone concentrations, whereas TC10 did not. On the other hand, TC10 increased the plasma concentration of glucagon-like peptide-1 (GLP-1), the hormone that promotes insulin secretion. The administration of the GLP-1 receptor antagonist, exendin(9–39), blocked the cognitive-enhancing effects of TC10. These results suggest that TC10 improved cognitive function via the GLP-1 receptor. The in vitro experiment indicated that 2-monocaprin (2-MC10), not TC10, stimulated the secretion of GLP-1 and decreased intracellular cAMP concentrations. In conclusion, we herein demonstrated that TC8 and TC10 attenuated cognitive decline through different mechanisms. This is the first study to suggest that TC10 attenuates cognitive decline via GLP-1.
- 26 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Open AccessMedium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1
Population aging is the most important social and medical demographic issue worldwide; therefore, healthy aging is important. The increasing prevalence of dementia and cognitive decline are major health concerns. Medium-chain triglycerides (MCTs) have been shown to improve cognitive decline. The present study investigated the effects and mechanisms of action of orally administered MCTs, including tricaprylin (TC8), tricaprin (TC10), and trilaurin (TC12), on cognitive function in mice fed a high-fat diet (HFD). The administration of TC8 and TC10 attenuated cognitive decline. A relationship has been reported between cognitive dysfunction and impaired glucose metabolism. The administration of TC8 and TC10 also reduced blood glucose levels in the glucose tolerance test. Cognitive improvements by MCTs are widely attributed to the ketogenic effect. In the present study, TC8 significantly increased blood ketone concentrations, whereas TC10 did not. On the other hand, TC10 increased the plasma concentration of glucagon-like peptide-1 (GLP-1), the hormone that promotes insulin secretion. The administration of the GLP-1 receptor antagonist, exendin(9–39), blocked the cognitive-enhancing effects of TC10. These results suggest that TC10 improved cognitive function via the GLP-1 receptor. The in vitro experiment indicated that 2-monocaprin (2-MC10), not TC10, stimulated the secretion of GLP-1 and decreased intracellular cAMP concentrations. In conclusion, we herein demonstrated that TC8 and TC10 attenuated cognitive decline through different mechanisms. This is the first study to suggest that TC10 attenuates cognitive decline via GLP-1.
- Open Access
- 13 June 2024
- Published by Elsevier in Journal of Functional Foods
- Vol. 119
A plant-derived δ opioid receptor agonist rubiscolin-6 ameliorates sickness behavior in mice with cancer cachexia
- 13 June 2024
- Published by Elsevier in Journal of Functional Foods
- Vol. 119
Open AccessA plant-derived δ opioid receptor agonist rubiscolin-6 ameliorates sickness behavior in mice with cancer cachexia
- Open Access
- 10 June 2024
- Published by Wiley in FASEB BioAdvances
- Vol. 6 (7) , 177-188
Ovomemolins: Egg‐derived peptides that improved cognitive decline after oral administration in mice
Eggs not only contain all the molecules necessary to nurture new life but are also rich in nutrients such as high‐quality protein. For example, epidemiologic studies have shown that egg intake is positively correlated with cognitive function. Thus, we specifically examined the effect of ovalbumin, a major protein present in egg whites, on cognitive function. First, we found that an orally administered enzymatic digest of ovalbumin improves cognitive function in mice fed a high‐fat diet. Then, we narrowed down candidate peptides based on the prediction of peptide production according to enzyme‐substrate specificity and comprehensive peptide analysis of the digest. We found that three peptides, namely ILPEY, LYRGGLEP, and ILELP, improve cognitive function after oral administration. We also showed that ILPEY, LYRGGLEP, and ILELP were present in the digest and named them ovomemolins A (OMA), B, and C, respectively. Notably, ovomemolins are the first peptides derived from egg whites that have been shown to improve cognitive function. The cognitive improvement induced by OMA, the most abundant of the peptides in the digest, was inhibited by methyllycaconitine, an antagonist of α7nAChR, which is known to be related to memory. These results suggest that OMA improves cognitive function through the acetylcholine system. After OMA administration, brain‐derived neurotrophic factor (BDNF) mRNA expression and the number of 5‐bromo‐2′‐deoxyuridine‐positive cells suggested that OMA increases hippocampal BDNF expression and neurogenesis.
- 10 June 2024
- Published by Wiley in FASEB BioAdvances
- Vol. 6 (7) , 177-188
Open AccessOvomemolins: Egg‐derived peptides that improved cognitive decline after oral administration in mice
Eggs not only contain all the molecules necessary to nurture new life but are also rich in nutrients such as high‐quality protein. For example, epidemiologic studies have shown that egg intake is positively correlated with cognitive function. Thus, we specifically examined the effect of ovalbumin, a major protein present in egg whites, on cognitive function. First, we found that an orally administered enzymatic digest of ovalbumin improves cognitive function in mice fed a high‐fat diet. Then, we narrowed down candidate peptides based on the prediction of peptide production according to enzyme‐substrate specificity and comprehensive peptide analysis of the digest. We found that three peptides, namely ILPEY, LYRGGLEP, and ILELP, improve cognitive function after oral administration. We also showed that ILPEY, LYRGGLEP, and ILELP were present in the digest and named them ovomemolins A (OMA), B, and C, respectively. Notably, ovomemolins are the first peptides derived from egg whites that have been shown to improve cognitive function. The cognitive improvement induced by OMA, the most abundant of the peptides in the digest, was inhibited by methyllycaconitine, an antagonist of α7nAChR, which is known to be related to memory. These results suggest that OMA improves cognitive function through the acetylcholine system. After OMA administration, brain‐derived neurotrophic factor (BDNF) mRNA expression and the number of 5‐bromo‐2′‐deoxyuridine‐positive cells suggested that OMA increases hippocampal BDNF expression and neurogenesis.
- Open Access
- 7 March 2024
- Published by Elsevier in Neuroscience Research
- Vol. 205, 34-39
Fatty acid amides present in Camembert cheese improved cognitive decline after oral administration in mice
- 7 March 2024
- Published by Elsevier in Neuroscience Research
- Vol. 205, 34-39
Open AccessFatty acid amides present in Camembert cheese improved cognitive decline after oral administration in mice
- 7 March 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 88 (6) , 671-678
Human milk-specific fat components enhance the secretion of ghrelin by MGN3-1 cells
Triacylglycerols (TAGs) are a major fat component in human milk. Since gastric lipase produces 1,2-diacylglycerol from TAGs, we focused on the bioactivity of human milk-derived diacylglycerols in stomach cells. Ghrelin is produced in the stomach and acts as an important regulator of growth hormone secretion and energy homeostasis. In this study, we showed that 1-oleoyl-2-palmitoylglycerol (OP) increased ghrelin secretion, whereas 1,3-dioleoyl-2-palmitoylglycerol (OPO), a major component of human milk TAGs, did not increase ghrelin secretion in the ghrelin-secreting cell line, MGN3-1. Therefore, diacylglycerol OP may directly contribute to the regulation of ghrelin secretion. We also found that 2-palmitoylglycerol and 1- and 2-oleoylglycerol increased ghrelin secretion. Finally, we demonstrated that intracellular cAMP levels and preproghrelin and ghrelin O-acyl transferase expression levels were enhanced by OP treatment in MGN3-1 cells. This may represent an example of a novel mother-infant interaction mediated by fat components derived from human breast milk.
- 7 March 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 88 (6) , 671-678
Human milk-specific fat components enhance the secretion of ghrelin by MGN3-1 cells
Triacylglycerols (TAGs) are a major fat component in human milk. Since gastric lipase produces 1,2-diacylglycerol from TAGs, we focused on the bioactivity of human milk-derived diacylglycerols in stomach cells. Ghrelin is produced in the stomach and acts as an important regulator of growth hormone secretion and energy homeostasis. In this study, we showed that 1-oleoyl-2-palmitoylglycerol (OP) increased ghrelin secretion, whereas 1,3-dioleoyl-2-palmitoylglycerol (OPO), a major component of human milk TAGs, did not increase ghrelin secretion in the ghrelin-secreting cell line, MGN3-1. Therefore, diacylglycerol OP may directly contribute to the regulation of ghrelin secretion. We also found that 2-palmitoylglycerol and 1- and 2-oleoylglycerol increased ghrelin secretion. Finally, we demonstrated that intracellular cAMP levels and preproghrelin and ghrelin O-acyl transferase expression levels were enhanced by OP treatment in MGN3-1 cells. This may represent an example of a novel mother-infant interaction mediated by fat components derived from human breast milk.
- Open Access
The Effect of the Rice Endosperm Protein Hydrolysate on the Subjective Negative Mood Status in Healthy Humans: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
The rice endosperm protein (REP) hydrolysate containing the following rice endosperm protein derived oligopeptides QQFLPEGQSQSQK, LPEGQSQSQK, and pEQFLPEGQSQSQK (a N-terminal pyroglutamate residue-modified peptide) reportedly showed an antidepressant-like effect in an animal model. We investigated the effect of the REP hydrolysate on healthy humans who self-reported mental fatigue with subjectively low vigor. Seventy-six participants (age: 20–64 years) were randomly allocated to two groups. The influence of the REP hydrolysate on the mood state was evaluated in two studies: single intake (Study 1) and repeated intake over 4 weeks (Study 2). A salivary stress marker, Chromogranin A (CgA), was measured in Study 1. The single intake of the REP hydrolysate significantly improved the Profile of Mood Status 2nd edition for adults (POMS 2) subscale of Tension–Anxiety. Additionally, the salivary CgA concentrations were remarkably reduced after the single intake of the REP hydrolysate. Though a single intake of the REP hydrolysate did not significantly influence the other subscales and the TMD of the POMS 2 and the Euthymia Scale, both the subjective and objective results supported the possible effect of the REP hydrolysate on reducing anxiety and nervousness. No significant positive effects on the subjective mood state (Euthymia Scale and POMS 2) and sleep quality (Insomnia Severity Index) were observed in the trial setting employed for Study 2. In conclusion, a single intake of REP hydrolysate might help relax the subjective feelings of tension and anxiety. The effectiveness of repeated REP hydrolysate intake needs to be tested in a different clinical setting.
Open AccessThe Effect of the Rice Endosperm Protein Hydrolysate on the Subjective Negative Mood Status in Healthy Humans: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
The rice endosperm protein (REP) hydrolysate containing the following rice endosperm protein derived oligopeptides QQFLPEGQSQSQK, LPEGQSQSQK, and pEQFLPEGQSQSQK (a N-terminal pyroglutamate residue-modified peptide) reportedly showed an antidepressant-like effect in an animal model. We investigated the effect of the REP hydrolysate on healthy humans who self-reported mental fatigue with subjectively low vigor. Seventy-six participants (age: 20–64 years) were randomly allocated to two groups. The influence of the REP hydrolysate on the mood state was evaluated in two studies: single intake (Study 1) and repeated intake over 4 weeks (Study 2). A salivary stress marker, Chromogranin A (CgA), was measured in Study 1. The single intake of the REP hydrolysate significantly improved the Profile of Mood Status 2nd edition for adults (POMS 2) subscale of Tension–Anxiety. Additionally, the salivary CgA concentrations were remarkably reduced after the single intake of the REP hydrolysate. Though a single intake of the REP hydrolysate did not significantly influence the other subscales and the TMD of the POMS 2 and the Euthymia Scale, both the subjective and objective results supported the possible effect of the REP hydrolysate on reducing anxiety and nervousness. No significant positive effects on the subjective mood state (Euthymia Scale and POMS 2) and sleep quality (Insomnia Severity Index) were observed in the trial setting employed for Study 2. In conclusion, a single intake of REP hydrolysate might help relax the subjective feelings of tension and anxiety. The effectiveness of repeated REP hydrolysate intake needs to be tested in a different clinical setting.
- Open Access
- 1 March 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (4) , e22836
Soy‐ f ortelin: A ghrelin sensitivity‐enhancing peptide that stimulates food intake in aged mice
Ghrelin sensitivity is known to decrease with aging in mice and humans, and the decrease contributes to anorexia with aging. In this study, we discovered novel ghrelin sensitivity‐enhancing peptides. Ghrelin sensitivity was evaluated by examining whether dipeptide samples enhanced the calcium response to ghrelin in the growth hormone secretagogue receptor‐transfected cell line. First, dipeptides were screened using a 336‐dipeptide library and we revealed that Ser‐Tyr (SY) potentiated ghrelin sensitivity in particular. Based on the structure‐activity relationship determined using the dipeptide library and comprehensive analysis of peptides in the chymotrypsin digest of soy β‐conglycinin (β‐CG), which enhanced ghrelin sensitivity, candidate peptides were narrowed down. Among the chemosynthesized peptides, we discovered that an undecapeptide, SLVNNDDRDSY, corresponding to β‐CGα(267‐277), stimulated ghrelin sensitivity in vitro . This peptide enhanced the orexigenic activity of ghrelin in C57BL/6 mice and stimulated food intake. Thus, we demonstrated that SLVNNDDRDSY stimulated ghrelin sensitivity in vitro and in vivo and named it “soy‐ f ortelin”. Moreover, orally administered soy‐ f ortelin had a similar but smaller effect in the young C57BL/6 mice, whereas it strongly stimulated food intake in 2‐year‐old aged mice that exhibited high blood ghrelin levels and low ghrelin sensitivity. In conclusion, we discovered soy‐ f ortelin as a novel peptide that enhances ghrelin sensitivity in vivo and in vitro and increases food intake in young and aged ghrelin‐resistant mice. Soy‐ f ortelin is the first food‐derived peptide reported to enhance ghrelin sensitivity.
- 1 March 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (4) , e22836
Open AccessSoy‐ f ortelin: A ghrelin sensitivity‐enhancing peptide that stimulates food intake in aged mice
Ghrelin sensitivity is known to decrease with aging in mice and humans, and the decrease contributes to anorexia with aging. In this study, we discovered novel ghrelin sensitivity‐enhancing peptides. Ghrelin sensitivity was evaluated by examining whether dipeptide samples enhanced the calcium response to ghrelin in the growth hormone secretagogue receptor‐transfected cell line. First, dipeptides were screened using a 336‐dipeptide library and we revealed that Ser‐Tyr (SY) potentiated ghrelin sensitivity in particular. Based on the structure‐activity relationship determined using the dipeptide library and comprehensive analysis of peptides in the chymotrypsin digest of soy β‐conglycinin (β‐CG), which enhanced ghrelin sensitivity, candidate peptides were narrowed down. Among the chemosynthesized peptides, we discovered that an undecapeptide, SLVNNDDRDSY, corresponding to β‐CGα(267‐277), stimulated ghrelin sensitivity in vitro . This peptide enhanced the orexigenic activity of ghrelin in C57BL/6 mice and stimulated food intake. Thus, we demonstrated that SLVNNDDRDSY stimulated ghrelin sensitivity in vitro and in vivo and named it “soy‐ f ortelin”. Moreover, orally administered soy‐ f ortelin had a similar but smaller effect in the young C57BL/6 mice, whereas it strongly stimulated food intake in 2‐year‐old aged mice that exhibited high blood ghrelin levels and low ghrelin sensitivity. In conclusion, we discovered soy‐ f ortelin as a novel peptide that enhances ghrelin sensitivity in vivo and in vitro and increases food intake in young and aged ghrelin‐resistant mice. Soy‐ f ortelin is the first food‐derived peptide reported to enhance ghrelin sensitivity.
- Open Access
- 18 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Rice-memolin, a novel peptide derived from rice bran, improves cognitive function after oral administration in mice
Many people eat polished rice, while rice bran, a by-product known to be rich in protein and expected to have potential functions for health benefits, has not been effectively utilized. In this study, we determined that orally administered Val-Tyr-Thr-Pro-Gly (VYTPG) derived from rice bran protein improved cognitive decline in mice fed a high-fat diet (HFD). It was demonstrated that VYTPG was released from model peptides corresponding to fragment sequences of original rice proteins (Os01g0941500, Os01g0872700, and allergenic protein) after treatment with thermolysin, a microorganism-derived enzyme often used in industrial scale processes. The thermolysin digest also improved cognitive decline after oral administration in mice. Because VYTPG (1.0 mg/kg) potently improved cognitive decline and is enzymatically produced from the rice bran, we named it rice-memolin. Next, we investigated the mechanisms underlying the cognitive decline improvement associated with rice-memolin. Methyllycaconitine, an antagonist for α7 nicotinic acetylcholine receptor, suppressed the rice-memolin-induced effect, suggesting that rice-memolin improved cognitive decline coupled to the acetylcholine system. Rice-memolin increased the number of 5-bromo-2’-deoxyuridine (BrdU)-positive cells and promoted the mRNA expression of EGF and FGF-2 in the hippocampus, implying that these neurotropic factors play a role in hippocampal neurogenesis after rice-memolin administration. Epidemiologic studies demonstrated that diabetes is a risk factor for dementia; therefore, we also examined the effect of rice-memolin on glucose metabolism. Rice-memolin improved glucose intolerance. In conclusion, we identified a novel rice-derived peptide that can improve cognitive decline. The mechanisms are associated with acetylcholine and hippocampal neurogenesis. Rice-memolin is the first rice-brain-derived peptide able to improve cognitive decline.
- 18 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Open AccessRice-memolin, a novel peptide derived from rice bran, improves cognitive function after oral administration in mice
Many people eat polished rice, while rice bran, a by-product known to be rich in protein and expected to have potential functions for health benefits, has not been effectively utilized. In this study, we determined that orally administered Val-Tyr-Thr-Pro-Gly (VYTPG) derived from rice bran protein improved cognitive decline in mice fed a high-fat diet (HFD). It was demonstrated that VYTPG was released from model peptides corresponding to fragment sequences of original rice proteins (Os01g0941500, Os01g0872700, and allergenic protein) after treatment with thermolysin, a microorganism-derived enzyme often used in industrial scale processes. The thermolysin digest also improved cognitive decline after oral administration in mice. Because VYTPG (1.0 mg/kg) potently improved cognitive decline and is enzymatically produced from the rice bran, we named it rice-memolin. Next, we investigated the mechanisms underlying the cognitive decline improvement associated with rice-memolin. Methyllycaconitine, an antagonist for α7 nicotinic acetylcholine receptor, suppressed the rice-memolin-induced effect, suggesting that rice-memolin improved cognitive decline coupled to the acetylcholine system. Rice-memolin increased the number of 5-bromo-2’-deoxyuridine (BrdU)-positive cells and promoted the mRNA expression of EGF and FGF-2 in the hippocampus, implying that these neurotropic factors play a role in hippocampal neurogenesis after rice-memolin administration. Epidemiologic studies demonstrated that diabetes is a risk factor for dementia; therefore, we also examined the effect of rice-memolin on glucose metabolism. Rice-memolin improved glucose intolerance. In conclusion, we identified a novel rice-derived peptide that can improve cognitive decline. The mechanisms are associated with acetylcholine and hippocampal neurogenesis. Rice-memolin is the first rice-brain-derived peptide able to improve cognitive decline.